Low Dose of Lenalidomide Enhances NK Cell Activity: Possible Implication as an Adjuvant
<strong>Background:</strong> Lenalidomide, a synthetic immunomodulatory drug, has a wide range of features including anti-angiogenic and anti-proliferative properties. To date, researchers have shown that lenalidomide is capable of ameliorating the immune system factors and antitumor res...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shiraz University of Medical Sciences
2017-06-01
|
| Series: | Iranian Journal of Immunology |
| Subjects: | |
| Online Access: | http://iji.sums.ac.ir/article_39305_6d3e722f67151005e60e2095c02f8d60.pdf |